Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription.

The EMBO journal | Sep 15, 2000

http://www.ncbi.nlm.nih.gov/pubmed/10990461

Induction of NF-kappaB-dependent transcription requires phosphorylation and subsequent degradation of I-kappaB, an inhibitor of NF-kappaB, followed by nuclear translocation and DNA binding of NF-kappaB. Tumor necrosis factor receptor-associated factor 2 (TRAF2) plays a role in NF-kappaB activation in response to cytokines such as tumor necrosis factor alpha (TNFalpha). In this study, we purified and characterized a novel kinase (T2K, also known as TBK1 or NAK), which associates with TRAF2 and exhibits kinase activity towards I-kappaBalpha in vitro. The physiological function of T2K was investigated using T2K-deficient mice. Heterozygotes appear normal, but t2k(-/-) animals die at approximately E14.5 of massive liver degeneration and apoptosis. Never theless, hematopoietic progenitors from T2K-deficient fetal liver support normal lymphocyte development. Furthermore, t2k(-/-) embryonic fibroblasts and thymocytes do not display increased sensitivity to TNFalpha-induced apoptosis. In response to either TNFalpha or IL-1 induction, t2k(-/-) embryonic fibroblasts exhibit normal degradation of I-kappaB and kappaB-binding activity. However, NF-kappaB-directed transcription is dramatically reduced. These results demonstrate that, like I-kappaB kinase beta and the RelA subunit of NF-kappaB, T2K is critical in protecting embryonic liver from apoptosis. However, T2K has a unique role in the activation of NF-kappaB-directed transcription, apparently independent of I-kappaB degradation and NF-kappaB DNA binding.

Pubmed ID: 10990461 RIS Download

Mesh terms: Amino Acid Sequence | Animals | Apoptosis | Blotting, Southern | Cycloheximide | Dose-Response Relationship, Drug | Female | Fibroblasts | Flow Cytometry | Gene Targeting | Genes, Reporter | Genotype | Heterozygote | I-kappa B Kinase | In Situ Nick-End Labeling | Interleukin-1 | Ligases | Liver | Lymphocytes | Male | Mice | Mice, Inbred C57BL | Mice, Transgenic | Models, Genetic | Molecular Sequence Data | NF-kappa B | Phosphorylation | Precipitin Tests | Protein Binding | Protein Synthesis Inhibitors | Protein-Serine-Threonine Kinases | Proteins | Recombinant Proteins | TNF Receptor-Associated Factor 2 | Thymus Gland | Time Factors | Transcription, Genetic | Tumor Necrosis Factor-alpha

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.